A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2
Open accessAbstract
Genes mutated in patients with Fanconi anemia (FA) interact with the DNA repair genes BRCA1 and BRCA2/FANCD1 to suppress tumorigenesis, but the molecular functions ascribed to them cannot fully explain all of their cellular roles. Here, we show a repair-independent requirement for FA genes, including FANCD2, and BRCA1 in protecting stalled replication forks from degradation. Fork protection is surprisingly rescued in FANCD2-deficient cells by elevated RAD51 levels or stabilized RAD51 filaments. Moreover, FANCD2-mediated fork protection is epistatic with RAD51 functions, revealing an unanticipated fork protection pathway that connects FA genes to RAD51 and the BRCA1/2 breast cancer suppressors. Collective results imply a unified molecular mechanism for repair-independent functions of FA, RAD51, and BRCA1/2 proteins in preventing genomic instability and suppressing tumorigenesis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BRCA1 is implicated in a repair-independent mechanism that protects stalled replication forks from degradation.
“BRCA1 is implicated in a repair-independent mechanism in protecting stalled replication forks from degradation to maintain genome stability (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
BRCA1-deficient cells show significant shortening of fork length after hydroxyurea treatment, indicating degradation of stalled replication forks.
“As previously shown, BRCA1-deficient cells show significant shortening of fork length following hydroxyurea (HU) treatment indicating degradation of stalled replication forks.”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
Abraxas is not required for efficient replication restart after hydroxyurea treatment.
“In addition, Abraxas did not appear to be required for efficient replication restart after HU treatment (data not shown), consistent with published observation that BRCA1 is not required for replication recovery (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,258 · see citing works
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245 · see citing works
Self-citationInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198 · see citing works
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858 · see citing works
Advanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791 · see citing works
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635 · see citing works
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 586 · see citing works
Rad51 protects nascent DNA from Mre11 dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Chaudhuri, A., Lopes, M., & Costanzo, V. (2010) · Nature Structural &Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 540 · see citing works
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 515 · see citing works
Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice
Langevin, F., Crossan, G. P., Rosado, I. V., Arends, M. J., & Patel, K. J. (2011) · Nature · doi:10.1038/nature10192 · Cited by 499 · see citing works
Mre11 Dimers Coordinate DNA End Bridging and Nuclease Processing in Double-Strand-Break Repair
Williams, R. S., Moncalián, G., Williams, J. S., Yamada, Y., Limbo, O., Shin, D. S., Groocock, L., Cahill, D., Hitomi, C., Guenther, G., et al. (2008) · Cell · doi:10.1016/j.cell.2008.08.017 · Cited by 496 · see citing works
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
Gowen, L. C., Johnson, B. L., Latour, A. M., Sulik, K. K., & Koller, B. H. (1996) · Nature Genetics · doi:10.1038/ng0296-191 · Cited by 480 · see citing works
RecQ helicases: multifunctional genome caretakers
Chu, W.-K., & Hickson, I. (2009) · Nature Reviews. Cancer · doi:10.1038/nrc2682 · Cited by 470 · see citing works
A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
Dupré, A., Boyer-Châtenet, L., Sattler, R. M., Modi, A. P., Lee, J., Nicolette, M. L., Kopelovich, L., Jasin, M., Baer, R. J., Paull, T. T., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.63 · Cited by 416 · see citing works
Self-citationPositional Cloning of a Novel Fanconi Anemia Gene, FANCD2
Timmers, C. D., Taniguchi, T., Hejna, J., Reifsteck, C. A., Lucas, L., Bruun, D. A., Thayer, M., Cox, B., Olson, S. B., D’Andrea, A. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00172-1 · Cited by 399 · see citing works
Susceptibility Pathways in Fanconi's Anemia and Breast Cancer
D’Andrea, A. D. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809889 · Cited by 380 · see citing works
A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage
Wang, J., Sun, Q., Morita, Y., Jiang, H., Groß, A., Lechel, A., Hildner, K., Guachalla, L. M., Gompf, A., Hartmann, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.040 · Cited by 343 · see citing works
Naim, V., & Rosselli, F. (2009) · Nature Cell Biology · doi:10.1038/ncb1883 · Cited by 335 · see citing works
Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin
Wang, X., Andreassen, P. R., & D’Andrea, A. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5850-5862.2004 · Cited by 332 · see citing works
Spontane Chromosomenaberrationen bei famili�rer Panmyelopathie
Schroeder, T. M., Ansch�tz, F., & Knopp, A. (1964) · Human Genetics · doi:10.1007/bf00389636 · Cited by 310 · see citing works
Howlett, N. G., Taniguchi, T., Durkin, S. G., D’Andrea, A. D., & Glover, T. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi065 · Cited by 279 · see citing works
Elevated levels of Rad51 recombination protein in tumor cells.
Raderschall, E., Stout, K., Freier, S., Suckow, V., Schweiger, S., & Haaf, T. (2002) · PubMed · Cited by 257 · see citing works
Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility proteinPreprint
Lomonosov, M., Anand, S., Sangrithi, M. N., Davies, R. C., & Venkitaraman, A. R. (2003) · Genes & Development · doi:10.1101/gad.279003 · Cited by 256 · see citing works
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
Bunting, S. F., Callén, E., Kozak, M. L., Kim, J. M., Wong, N., López-Contreras, A. J., Ludwig, T., Baer, R., Faryabi, R. B., Malhowski, A., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.015 · Cited by 252 · see citing works
FANCM Connects the Genome Instability Disorders Bloom's Syndrome and Fanconi Anemia
Deans, A. J., & West, S. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.006 · Cited by 245 · see citing works
Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair
Long, D. T., Räschle, M., Joukov, V., & Walter, J. C. (2011) · Science · doi:10.1126/science.1204258 · Cited by 238 · see citing works
Role for BLM in replication-fork restart and suppression of origin firing after replicative stress
Davies, S. L., North, P. S., & Hickson, I. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1267 · Cited by 234 · see citing works
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hussain, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh135 · Cited by 207 · see citing works
Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway
Rosado, I. V., Langevin, F., Crossan, G. P., Takata, M., & Patel, K. J. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2173 · Cited by 184 · see citing works
Regulation of Rev1 by the Fanconi anemia core complex
Kim, H., Yang, K., Dejsuphong, D., & D’Andrea, A. D. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2222 · Cited by 137 · see citing works
Functional Activity of the Fanconi Anemia Protein FAA Requires FAC Binding and Nuclear Localization
Näf, D., Kupfer, G. M., Suliman, A., Lambert, K., & D’Andrea, A. D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5952 · Cited by 125 · see citing works
Papadopoulo, D., Guillouf, C., Mohrenweiser, H. W., & Moustacchi, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8383 · Cited by 120 · see citing works
The Essential Functions of Human Rad51 Are Independent of ATP Hydrolysis
Morrison, C. G., Shinohara, A., Sonoda, E., Yamaguchi‐Iwai, Y., Takata, M., Weichselbaum, R. R., & Takeda, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6891 · Cited by 116 · see citing works
Raderschall, E., Bazarov, A., Cao, J., Lurz, R., Smith, A., Mann, W., Ropers, H., Sedivy, J. M., Golub, E. I., Fritz, E., et al. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.1.153 · Cited by 97 · see citing works
Suppression of the DNA repair defects of BRCA2-deficient cells with heterologous protein fusions
Saeki, H., Siaud, N., Christ, N., Wiegant, W. W., van Buul, P. P. W., Han, M., Zdzienicka, M. Z., Stark, J. M., & Jasin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600298103 · Cited by 95 · see citing works
Self-citationPark, J. W., Pitot, H. C., Strati, K., Spardy, N. A., Duensing, S. M., Grompe, M., & Lambert, P. F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1291 · Cited by 85 · see citing works
Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication
Nakanishi, K., Cavallo, F., Perrouault, L., Giovannangeli, C., Moynahan, M. E., Barchi, M., Brunet, E., & Jasin, M. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2029 · Cited by 79 · see citing works
Self-citationGenome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene
Yusa, K., Horie, K., Kondoh, G., Kouno, M., Maeda, Y., Kinoshita, T., & Takeda, J. (2004) · Nature · doi:10.1038/nature02646 · Cited by 76 · see citing works
Howlett, N. G., Harney, J. A., Rego, M. A., Kolling, F. W., & Glover, T. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016352 · Cited by 60 · see citing works
Cybulski, K. E., & Howlett, N. G. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15818 · Cited by 53 · see citing works
Rad51 overexpression rescues radiation resistance in BRCA2‐defective cancer cells
Brown, E. T., & Holt, J. T. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20463 · Cited by 51 · see citing works
FANCJ: Solving problems in DNA replication
Hiom, K. J. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.01.005 · Cited by 40 · see citing works
Immortalization of four new fanconi anemia fibroblast cell lines by an improved procedure
Jakobs, P. M., Sahaayaruban, P., Saito, H., Reifsteck, C. A., Olson, S. B., Joenje, H., Moses, R. E., & Grompe, M. (1996) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02369905 · Cited by 32 · see citing works
A touching moment for Smc5/6: From ssDNA binding to repair
Ohouo, P. Y., & Smolka, M. B. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15380 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Causes and consequences of replication stress
Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079 · see citing works
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786 · see citing works
DNA double-strand break repair-pathway choice in somatic mammalian cells
Scully, R., Panday, A., Elango, R., & Willis, N. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0152-0 · Cited by 1,445 · see citing works
Gaillard, H., García‐Muse, T., & Aguilera, A. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3916 · Cited by 1,076 · see citing works
Replication fork stability confers chemoresistance in BRCA-deficient cells
Chaudhuri, A. R., Callén, E., Ding, X., Gogola, E., Duarte, A. A., Lee, J., Wong, N., Lafarga, V., Calvo, J. A., Panzarino, N. J., et al. (2016) · Nature · doi:10.1038/nature18325 · Cited by 917 · see citing works
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869 · see citing works
Self-citationTargeting DNA damage response pathways in cancer
Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N., & Tarsounas, M. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00535-5 · Cited by 868 · see citing works
R loops: new modulators of genome dynamics and function
Santos-Pereira, J. M., & Aguilera, A. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3961 · Cited by 752 · see citing works
A decade of clinical development of PARP inhibitors in perspective
Mateo, J., Lord, C. J., Serra, V., Tutt, A., Balmaña, J., Castroviejo-Bermejo, M., Cruz, C., Oaknin, A., Kaye, S. B., & de Bono, J. S. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz192 · Cited by 743 · see citing works
The Fanconi anaemia pathway: new players and new functions
Ceccaldi, R., Sarangi, P., & D’Andrea, A. D. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.48 · Cited by 705 · see citing works
PARP and PARG inhibitors in cancer treatmentPreprint
Slade, D. (2020) · Genes & Development · doi:10.1101/gad.334516.119 · Cited by 666 · see citing works
Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells
Zellweger, R., Dalcher, D., Mutreja, K., Berti, M., Schmid, J. A., Herrador, R., Vindigni, A., & Lopes, M. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201406099 · Cited by 660 · see citing works
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks
Kottemann, M. C., & Smogorzewska, A. (2013) · Nature · doi:10.1038/nature11863 · Cited by 608 · see citing works
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Xu, H., Antonio, M. D., McKinney, S. E., Mathew, V., Ho, B., O’Neil, N. J., Santos, N. D., Silvester, J., Wei, V., Garcia, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14432 · Cited by 574 · see citing works
PARP inhibitor resistance: the underlying mechanisms and clinical implications
Li, H., Liu, Z., Wu, N., Chen, Y., Cheng, Q., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01227-0 · Cited by 558 · see citing works
BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2
Bhatia, V., Barroso, S. I., García-Rubio, M. L., Tumini, E., Herrera‐Moyano, E., & Aguilera, A. (2014) · Nature · doi:10.1038/nature13374 · Cited by 527 · see citing works
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Dias, M. P., Moser, S. C., Ganesan, S., & Jonkers, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00532-x · Cited by 526 · see citing works
Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
Jaspers, J. E., Kersbergen, A. J., Boon, U., Sol, W., van Deemter, L., Zander, S. A. L., Drost, R., Wientjens, E., Ji, J. J., Aly, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0049 · Cited by 515 · see citing works
High speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514 · see citing works
Replication fork reversal in eukaryotes: from dead end to dynamic response
Neelsen, K. J., & Lopes, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3935 · Cited by 494 · see citing works
Mechanisms of PARP inhibitor sensitivity and resistance
D’Andrea, A. D. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.08.021 · Cited by 488 · see citing works
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Noordermeer, S. M., & van Attikum, H. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.07.008 · Cited by 458 · see citing works
Hallmarks of DNA replication stress
Saxena, S., & Zou, L. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.004 · Cited by 442 · see citing works
Identification of Early Replicating Fragile Sites that Contribute to Genome Instability
Barlow, J. H., Faryabi, R. B., Callén, E., Wong, N., Malhowski, A. J., Chen, H. T., Gutierrez-Cruz, G., Sun, H., McKinnon, P. J., Wright, G. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.006 · Cited by 433 · see citing works
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Kotsantis, P., Petermann, E., & Boulton, S. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1461 · Cited by 416 · see citing works
Lemacon, D. S., Jackson, J., Quinet, A., Brickner, J. R., Li, S., Yazinski, S. A., You, Z., Ira, G., Zou, L., Mosammaparast, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01180-5 · Cited by 410 · see citing works
DNA repair mechanisms in cancer development and therapy
Torgovnick, A., & Schumacher, B. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00157 · Cited by 403 · see citing works
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
Zhao, W., Steinfeld, J. B., Liang, F., Chen, X., Maranon, D. G., Jian Ma, C., Kwon, Y., Rao, T., Wang, W., Sheng, C., et al. (2017) · Nature · doi:10.1038/nature24060 · Cited by 393 · see citing works
Yazinski, S. A., Comaills, V., Buisson, R., Genois, M., Nguyen, H. D., Ho, C. K., Kwan, T. T., Morris, R. T., Lauffer, S., Nussenzweig, A., et al. (2017) · Genes & Development · doi:10.1101/gad.290957.116 · Cited by 393 · see citing works
Taglialatela, A., Álvarez, S., Leuzzi, G., Sannino, V., Ranjha, L., Huang, J., Madubata, C. J., Anand, R., Levy, B., Rabadán, R., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.036 · Cited by 392 · see citing works
Syed, A., & Tainer, J. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012415 · Cited by 390 · see citing works
Fanconi anaemia and cancer: an intricate relationship
Nalepa, G., & Clapp, D. W. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.116 · Cited by 388 · see citing works
The Fanconi Anemia Pathway in Cancer
Joshi, N., Färkkilä, A., & D’Andrea, A. D. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050422 · Cited by 373 · see citing works
Kim, H., Xu, H., George, E. M., Hallberg, D. L., Kumar, S., Jagannathan, V., Medvedev, S., Kinose, Y., Devins, K. M., Verma, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17127-2 · Cited by 370 · see citing works
Hereditary breast and ovarian cancer: new genes in confined pathways
Nielsen, F. C., van Overeem Hansen, T., & Sørensen, C. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.72 · Cited by 367 · see citing works
Kolinjivadi, A. M., Sannino, V., Antoni, A. D., Zadorozhny, K., Kilkenny, M. L., Técher, H., Baldi, G., Shen, R., Ciccia, A., Pellegrini, L., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.001 · Cited by 366 · see citing works
Replication fork reversal triggers fork degradation in BRCA2-defective cells
Mijic, S., Zellweger, R., Chappidi, N., Berti, M., Jacobs, K., Mutreja, K., Ursich, S., Chaudhuri, A. R., Nussenzweig, A., Janščák, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01164-5 · Cited by 366 · see citing works
The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication
Tarsounas, M., & Sung, P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0218-z · Cited by 366 · see citing works
The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription
Schwab, R. A., Nieminuszczy, J., Shah, F., Langton, J., Martínez, D. L., Liang, C., Cohn, M. A., Gibbons, R. J., Deans, A. J., & Niedźwiedź, W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.012 · Cited by 356 · see citing works
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
Cong, K., Peng, M., Kousholt, A. N., Lee, W. T. C., Lee, S., Nayak, S. U., Krais, J. J., VanderVere-Carozza, P. S., Pawelczak, K. S., Calvo, J. A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.06.011 · Cited by 348 · see citing works
RPA and RAD51: fork reversal, fork protection, and genome stability
Bhat, K. P., & Cortez, D. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0075-z · Cited by 347 · see citing works
DNA2 drives processing and restart of reversed replication forks in human cells
Thangavel, S., Berti, M., Levikova, M., Pinto, C., Gomathinayagam, S., Vujanovic, M., Zellweger, R., Moore, H. R., Lee, E. H., Hendrickson, E. A., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201406100 · Cited by 341 · see citing works
The plasticity of DNA replication forks in response to clinically relevant genotoxic stress
Berti, M., Cortez, D., & Lopes, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0257-5 · Cited by 329 · see citing works
Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response
Elia, A. E. H., Boardman, A. P., Wang, D. C., Huttlin, E. L., Everley, R. A., Dephoure, N., Zhou, C., Koren, I., Gygi, S. P., & Elledge, S. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.006 · Cited by 324 · see citing works
Ranjha, L., Howard, S. M., & Ćejka, P. (2018) · Chromosoma · doi:10.1007/s00412-017-0658-1 · Cited by 324 · see citing works
Marra, A., Trapani, D., Viale, G., Criscitiello, C., & Curigliano, G. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00197-2 · Cited by 316 · see citing works
Chen, C.-C., Feng, W., Lim, P. X., Kass, E. M., & Jasin, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050502 · Cited by 313 · see citing works
Self-citationWerner syndrome: Clinical features, pathogenesis and potential therapeutic interventions
Oshima, J., Sidorova, J. M., & Monnat, R. J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.002 · Cited by 310 · see citing works
Johnson, S. F., Cruz, C., Greifenberg, A. K., Dust, S., Stover, D. G., Chi, D., Primack, B., Cao, S., Bernhardy, A. J., Coulson, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.077 · Cited by 291 · see citing works
DNA End Resection: Mechanism and Control
Ćejka, P., & Symington, L. S. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-020312 · Cited by 284 · see citing works
Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection
Densham, R. M., Garvin, A. J., Stone, H. R., Strachan, J., Baldock, R. A., Daza-Martín, M., Fletcher, A., Blair-Reid, S., Beesley, J. F. J., Johal, B., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3236 · Cited by 283 · see citing works
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Dietlein, F., Thelen, L., & Reinhardt, H. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.06.003 · Cited by 280 · see citing works
The impact of replication stress on replication dynamics and DNA damage in vertebrate cells
Técher, H., Koundrioukoff, S., Nicolas, A. G., & Debatisse, M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.46 · Cited by 271 · see citing works
Wang, A. T., Kim, T., Wagner, J. E., Conti, B. A., Lach, F. P., Huang, A. L., Molina, H., Sanborn, E. M., Zierhut, H. A., Cornes, B. K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.009 · Cited by 269 · see citing works
PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells
Quinet, A., Tirman, S., Jackson, J., Šviković, S., Lemacon, D. S., Carvajal-Maldonado, D., González‐Acosta, D., Vessoni, A. T., Cybulla, E., Wood, M. D., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.10.008 · Cited by 259 · see citing works
RAD51 Gene Family Structure and Function
Bonilla, B., Hengel, S. R., Grundy, M. K., & Bernstein, K. A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-021920-092410 · Cited by 259 · see citing works
Replication stress: getting back on track
Berti, M., & Vindigni, A. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3163 · Cited by 249 · see citing works
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Huang, D. Y., & Kraus, W. L. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.021 · Cited by 247 · see citing works
Lossaint, G., Larroque, M., Ribeyre, C., Bec, N., Larroque, C., Décaillet, C., Gari, K., & Constantinou, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.023 · Cited by 235 · see citing works
53BP1: a DSB escortPreprint
Mirman, Z., & de Lange, T. (2020) · Genes & Development · doi:10.1101/gad.333237.119 · Cited by 231 · see citing works
Ronson, G. E., Piberger, A. L., Higgs, M. R., Olsen, A. L., Stewart, G. D., McHugh, P. J., Petermann, E., & Lakin, N. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03159-2 · Cited by 227 · see citing works
Chromosome instability syndromes
Taylor, A. M. R., Rothblum‐Oviatt, C., Ellis, N. A., Hickson, I. D., Meyer, S., Crawford, T. O., Smogorzewska, A., Pietrucha, B. M., Weemaes, C. M. R., & Stewart, G. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0113-0 · Cited by 227 · see citing works
R Loops and Links to Human Disease
Richard, P., & Manley, J. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.031 · Cited by 218 · see citing works
Replication Gaps Underlie BRCA Deficiency and Therapy Response
Panzarino, N. J., Krais, J. J., Peng, M., Mosqueda, M., Nayak, S., Bond, S., Calvo, J. A., Cong, K., Doshi, M. B., Bere, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1602 · Cited by 209 · see citing works
Karst, A. M., Jones, P., Vena, N., Ligon, A. H., Liu, J. F., Hirsch, M. S., Etemadmoghadam, D., Bowtell, D. D. L., & Drapkin, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2247 · Cited by 207 · see citing works
Interplay between Fanconi anemia and homologous recombination pathways in genome integrity
Michl, J., Zimmer, J., & Tarsounas, M. (2016) · The EMBO Journal · doi:10.15252/embj.201693860 · Cited by 204 · see citing works
DNA repair defects in cancer and therapeutic opportunitiesPreprint
Hopkins, J. L., Lan, L., & Zou, L. (2022) · Genes & Development · doi:10.1101/gad.349431.122 · Cited by 204 · see citing works
Kais, Z., Rondinelli, B., Holmes, A. L., O’Leary, C., Kozono, D., D’Andrea, A. D., & Ceccaldi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.031 · Cited by 198 · see citing works
Dungrawala, H., Bhat, K. P., Meur, R. A. L., Chazin, W., Ding, X., Sharan, S. K., Wessel, S. R., Sathe, A. A., Zhao, R., & Cortez, D. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.023 · Cited by 195 · see citing works
BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks
Higgs, M. R., Reynolds, J. J., Winczura, A., Blackford, A. N., Borel, V., Miller, E. S., Zlatanou, A., Nieminuszczy, J., Ryan, E. L., Davies, N. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.007 · Cited by 194 · see citing works
The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy
Pavitra, E., Kancharla, J., Gupta, V. K., Prasad, K., Sung, J. Y., Kim, J., Tej, M. B., Choi, R., Lee, J., Han, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114822 · Cited by 194 · see citing works
The cGAS/STING Pathway: A Novel Target for Cancer Therapy
Gan, Y., Li, X., Han, S., Liang, Q., Ma, X., Rong, P., Wang, W., & Li, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795401 · Cited by 190 · see citing works
Liao, H., Ji, F., Helleday, T., & Ying, S. (2018) · EMBO Reports · doi:10.15252/embr.201846263 · Cited by 185 · see citing works
Bothmer, A., Phadke, T., Barrera, L. A., Margulies, C. M., Lee, C. S., Buquicchio, F. A., Moss, S., Abdulkerim, H. S., Selleck, W., Jayaram, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms13905 · Cited by 182 · see citing works
Carr, A. M., & Lambert, S. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.023 · Cited by 179 · see citing works
BRCA1 haploinsufficiency for replication stress suppression in primary cells
Pathania, S., Bade, S., Guillou, M. L., Burke, K. A., Reed, R., Bowman-Colin, C., Su, Y., Ting, D. T., Polyák, K., Richardson, A. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6496 · Cited by 178 · see citing works
RAD51 interconnects between DNA replication, DNA repair and immunity
Bhattacharya, S., Kalayarasan, S., Abdisalaam, S., Su, F., Raj, P., Dozmorov, I. M., Mishra, R., Wakeland, E. K., Ghose, S., Mukherjee, S., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx126 · Cited by 176 · see citing works
Taglialatela, A., Leuzzi, G., Sannino, V., Cuella-Martin, R., Huang, J., Wu-Baer, F., Baer, R. J., Costanzo, V., & Ciccia, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.016 · Cited by 176 · see citing works
USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors
Lim, K. S., Li, H., Roberts, E. A., Gaudiano, E. F., Clairmont, C. S., Sambel, L. A., Ponnienselvan, K., Liu, J., Yang, C., Kozono, D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.045 · Cited by 174 · see citing works
Hu, Y., Petit, S. A., Ficarro, S. B., Toomire, K. J., Xie, A., Lim, E., Cao, S. A., Park, E., Eck, M. J., Scully, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0891 · Cited by 171 · see citing works
Menghi, F., Barthel, F. P., Yadav, V. K., Tang, M., Ji, B., Tang, Z., Carter, G. W., Ruan, Y., Scully, R., Verhaak, R. G. W., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.008 · Cited by 169 · see citing works
Preserving replication fork integrity and competence via the homologous recombination pathway
Saada, A. A., Lambert, S., & Carr, A. M. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.08.017 · Cited by 169 · see citing works
Bayona‐Feliú, A., Barroso, S. I., Muñoz, S., & Aguilera, A. (2021) · Nature Genetics · doi:10.1038/s41588-021-00867-2 · Cited by 167 · see citing works
Genomic instability, inflammatory signaling and response to cancer immunotherapy
Chen, M., Linstra, R., & van Vugt, M. A. T. M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188661 · Cited by 166 · see citing works
Bacolla, A., Tainer, J. A., Vásquez, K. M., & Cooper, D. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw261 · Cited by 164 · see citing works
Defining and Modulating ‘BRCAness’
Byrum, A. K., Vindigni, A., & Mosammaparast, N. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.06.005 · Cited by 164 · see citing works
FANCD2 Facilitates Replication through Common Fragile Sites
Madireddy, A., Kosiyatrakul, S. T., Boisvert, R. A., Herrera‐Moyano, E., García-Rubio, M. L., Gerhardt, J., Vuono, E. A., Owen, N. M., Yan, Z., Olson, S. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.017 · Cited by 163 · see citing works
Lesion Bypass and the Reactivation of Stalled Replication Forks
Marians, K. J. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011921 · Cited by 163 · see citing works
The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination
Zhao, W., Wiese, C., Kwon, Y., Hromas, R., & Sung, P. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111058 · Cited by 161 · see citing works
Targeting the replication stress response in cancer
Forment, J. V., & O’Connor, M. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.005 · Cited by 159 · see citing works
Chen, Y.-H., Jones, M. V., Yin, Y., Crist, S. B., Colnaghi, L., Sims, R. J., Rothenberg, E., Jallepalli, P. V., & Huang, T. T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.031 · Cited by 158 · see citing works
Bayard, Q., Meunier, L., Péneau, C., Renault, V., Shinde, J., Nault, J., Mami, I., Couchy, G., Amaddeo, G., Tubacher, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07552-9 · Cited by 156 · see citing works
Mamrak, N. E., Shimamura, A., & Howlett, N. G. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.10.002 · Cited by 155 · see citing works
Zhang, X., Chiang, H.-C., Wang, Y., Zhang, C., Smith, S. A., Zhao, X., Nair, S. J., Michalek, J. E., Jatoi, I., Lautner, M. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15908 · Cited by 155 · see citing works
Feng, W., & Jasin, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00634-0 · Cited by 155 · see citing works
Self-citationAdvances in understanding DNA processing and protection at stalled replication forks
Rickman, K. A., & Smogorzewska, A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201809012 · Cited by 153 · see citing works
Kolinjivadi, A. M., Sannino, V., Antoni, A. D., Técher, H., Baldi, G., & Costanzo, V. (2017) · FEBS Letters · doi:10.1002/1873-3468.12556 · Cited by 152 · see citing works
Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
Manic, G., Obrist, F., Sistigu, A., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1012976 · Cited by 147 · see citing works
RAD-ical New Insights into RAD51 Regulation
Sullivan, M. R., & Bernstein, K. A. (2018) · Genes · doi:10.3390/genes9120629 · Cited by 144 · see citing works
Bouwman, P., van der Gulden, H., van der Heijden, I., Drost, R., Klijn, C. N., Prasetyanti, P., Pieterse, M., Wientjens, E., Seibler, J., Hogervorst, F. B. L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0094 · Cited by 140 · see citing works
- Authors
- Schlacher, K., Wu, H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Schlacher, Katharina
- Jasin, Maria
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 22
- Issue
- 1
- Pages
- 106-116
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3954744
- OpenAlex
- W2096380982
- Cited by
- 936
- References
- 46
- Citations by year
- 2026: 40 · 2025: 56 · 2024: 80 · 2023: 70 · 2022: 69 · 2021: 91 · 2020: 86 · 2019: 63 · 2018: 83 · 2017: 74 · 2016: 87 · 2015: 53 · 2014: 50 · 2013: 27 · 2012: 7
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA121110, P01-CA94060, P01CA094060)
- National Institute of General Medical Sciences (R01 GM54668, R01GM054668)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, replication fork protection, FANCD2, RAD51, BRCA1, BRCA2, DNA repair, epistasis, genomic instability, tumor suppression
- MeSH terms
- Cell Line, Transformed, DNA Replication, Fanconi Anemia, Humans, Genes, BRCA1, Genes, BRCA2, BRCA2 Protein, Genomic Instability, Rad51 Recombinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review